scholarly article | Q13442814 |
P2093 | author name string | A F Cheng | |
J M Ling | |||
E W Chan | |||
A W Lam | |||
P2860 | cites work | Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA). | Q32111444 |
Antimicrobial susceptibilities and molecular epidemiology of Salmonella enterica serotype enteritidis strains isolated in Hong Kong from 1986 to 1996. | Q33670355 | ||
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates | Q33690745 | ||
gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae | Q33699643 | ||
Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci | Q33700561 | ||
Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. | Q33971931 | ||
Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field | Q33977564 | ||
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli | Q33979064 | ||
Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. | Q33979406 | ||
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae | Q33983643 | ||
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children | Q34111805 | ||
DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. | Q34143286 | ||
Purification and characterization of DNA topoisomerase IV in Escherichia coli | Q34239371 | ||
Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance | Q35116590 | ||
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. | Q35122643 | ||
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. | Q35123629 | ||
Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. | Q35128319 | ||
A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. | Q35131092 | ||
Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. | Q35131579 | ||
Increasing quinolone resistance in Salmonella enterica serotype Enteritidis | Q37320143 | ||
Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium | Q37320182 | ||
Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals. | Q39445995 | ||
In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR | Q39474394 | ||
Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae | Q39652363 | ||
Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations | Q39780132 | ||
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene | Q39781656 | ||
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals | Q39781884 | ||
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. | Q39783862 | ||
Molecular characterization of the Salmonella typhimurium parE gene | Q40406523 | ||
Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment | Q40642659 | ||
Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants. | Q42743898 | ||
Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales-the current situation | Q43215879 | ||
Epidemiological analysis of Salmonella enterica serotype typhimurium from Hong Kong by ribotyping and pulsed-field gel electrophoresis | Q43602321 | ||
Molecular epidemiological analysis of Salmonella enterica serotype Derby infections in Hong Kong | Q43725288 | ||
Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella typhimurium DT104. | Q43861435 | ||
Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals | Q43990859 | ||
The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions | Q44148098 | ||
Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess | Q44516994 | ||
The emergence of ciprofloxacin resistance in Salmonella typhimurium | Q44879400 | ||
Ciprofloxacin resistance in Salmonella paratyphi A. | Q45176756 | ||
Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom | Q47754927 | ||
A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium | Q48070197 | ||
Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions | Q48092311 | ||
Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark | Q50120569 | ||
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis. | Q50125876 | ||
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. | Q50131892 | ||
Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella | Q50137231 | ||
Emerging resistance in Salmonella enterica serotype Typhi in Hong Kong | Q50137936 | ||
High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes | Q50158766 | ||
Quinolone resistance in salmonella: clinical experience | Q50464747 | ||
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. | Q54042955 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3567-3573 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong | |
P478 | volume | 47 |
Q92556871 | A Historical Review on Antibiotic Resistance of Foodborne Campylobacter |
Q36635661 | A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa |
Q50075445 | Alterations in the gyrA and parC genes in Salmonella spp. following in vitro exposure to fluoroquinolones |
Q49977119 | Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium |
Q46127340 | Analysis of ciprofloxacin-resistant Salmonella strains from swine, chicken, and their carcasses in Taiwan and detection of parC resistance mutations by a mismatch amplification mutation assay PCR. |
Q37723418 | Antimicrobial Resistance of Salmonella enterica Serovar Typhimurium in Shanghai, China |
Q33301096 | Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones |
Q38952157 | Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin. |
Q59126430 | Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa |
Q46264520 | Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China |
Q50082938 | Characterization of antimicrobial-resistant Salmonella isolated from imported foods |
Q34073412 | Characterization of isolates of Salmonella enterica serovar typhimurium displaying high-level fluoroquinolone resistance in Japan |
Q50042548 | Characterization of nalidixic acid-resistant and fluoroquinolone-reduced susceptible Salmonella Typhimurium in swine |
Q42619171 | Ciprofloxacin-resistant Salmonella Kentucky in travelers |
Q47350228 | Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi |
Q41810482 | Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials |
Q37160083 | Detection of quinolone-resistance mutations in salmonella spp. Strains of epidemic and poultry origin |
Q40652689 | Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of Salmonella Weltevreden and Newport isolated from seafood |
Q34384649 | Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa |
Q35666513 | Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France |
Q42540420 | Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India |
Q92710358 | Five Closed Salmonella enterica Genome Sequences from a 2017-2018 Multistrain, Multistate Kratom Outbreak |
Q95840911 | Genes and Proteomes Associated With Increased Mutation Frequency and Multidrug Resistance of Naturally Occurring Mismatch Repair-Deficient Salmonella Hypermutators |
Q44903067 | Geographically dependent distribution of gyrA gene mutations at codons 83 and 87 in Salmonella Hadar, and a novel codon 81 Gly to His mutation in Salmonella Enteritidis. |
Q37250819 | GyrA ser83 and ParC trp106 Mutations in Salmonella enterica Serovar Typhi Isolated from Typhoid Fever Patients in Tertiary Care Hospital. |
Q42768854 | High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan |
Q34073057 | Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure |
Q37334280 | International spread of multidrug-resistant Salmonella Schwarzengrund in food products |
Q35793904 | Molecular analysis of fluoroquinolone-resistant Salmonella Paratyphi A isolate, India |
Q40412595 | Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? |
Q35073518 | Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh |
Q50042895 | Molecular typing and antimicrobial resistance of Salmonella Enteritidis isolated from poultry, food, and humans in Serbia |
Q43169881 | Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators |
Q46610974 | Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea |
Q50092387 | Mutations in the quinolone-resistance determining region (QRDR) of Salmonella strains isolated from pigs in Spain. |
Q33555483 | Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones |
Q42376182 | Phenotypic and genotypic antimicrobial resistance and virulence genes of Salmonella enterica isolated from pet dogs and cats |
Q37322876 | Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil |
Q38097417 | Plasmid-mediated quinolone resistance--current knowledge and future perspectives |
Q37568371 | Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica |
Q46523427 | Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli |
Q37798457 | Quinolone and cephalosporin resistance in enteric fever |
Q42413026 | Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion |
Q40385789 | Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007. |
Q35807846 | Resistance phenotypes and genotypes among multiple-antimicrobial-resistant Salmonella enterica subspecies enterica serovar Choleraesuis strains isolated between 2008 and 2012 from slaughter pigs in Okinawa Prefecture, Japan |
Q35873023 | Salmonella Derby clonal spread from pork |
Q40414918 | Salmonella enterica Serotype typhi in Kuwait and its reduced susceptibility to ciprofloxacin |
Q50045251 | Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? |
Q92595570 | Salmonella enterica subsp. enterica Serovar Heidelberg Food Isolates Associated with a Salmonellosis Outbreak Have Enhanced Stress Tolerance Capabilities |
Q35626961 | Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India |
Q38983263 | The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana |
Q54099712 | Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle. |